Pathologic Features and Clinical Outcomes of HER2 FISH Cases with HER2: CEP17 ratio > 2.0 but < 4 HER2 signals/cell; A Multi-Institutional Study

被引：0
|
作者：
Ballard, Morgan [1 ]
Toukatly, Mirna [2 ]
Bean, Gregory [3 ]
Jalikis, Florencia [4 ]
Krings, Gregor [3 ]
Schmidt, Rodney [4 ]
Chen, Yunn-Yi [3 ]
Dintzis, Suzanne
Troxell, Megan [5 ]
West, Robert [6 ]
Sibley, Richard [5 ]
Allison, Kimberly [6 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Univ Washington, Med Ctr, Seattle, WA 98195 USA
[3] UCSF, San Francisco, CA USA
[4] Univ Washington, Seattle, WA 98195 USA
[5] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
[6] Stanford Univ, Stanford, CA 94305 USA
来源：
MODERN PATHOLOGY | 2018年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
139
引用
收藏
页码：47 / 48
页数：2
相关论文
共 50 条
  • [31] HER2/Neu Gene Amplification Heterogeneity: The Significance of Cells with a 3:1 HER2/CEP17 Ratio
    Layfield, L. J.
    Schmidt, R.
    LABORATORY INVESTIGATION, 2012, 92 : 49A - 49A
  • [32] A clinicopathological study and survival analysis of 99 breast cancers with HER2/CEP17 ratio ≥ 2.0 and an average HER2 copy number < 4.0 per cell in China
    Zhou, Shuling
    Lv, Hong
    Li, Anqi
    Li, Ming
    Zhong, Siyuan
    Lu, Hongfen
    Zhou, Xiaoyan
    Bai, Qianming
    Yang, Wentao
    BMC CANCER, 2023, 23 (01)
  • [33] HER2/neu Gene Amplification Heterogeneity: The Significance of Cells With a 3:1 HER2/CEP17 Ratio
    Layfield, Lester J.
    Schmidt, Robert L.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2012, 20 (06) : 543 - 549
  • [34] HER2/Neu Gene Amplification Heterogeneity: The Significance of Cells with a 3:1 HER2/CEP17 Ratio
    Layfield, L. J.
    Schmidt, R.
    MODERN PATHOLOGY, 2012, 25 : 49A - 49A
  • [35] Impact of Chromosome 17 and HER2 Copy Number Variability on HER2 FISH in Breast Cancer Cases with CEP17 Copy Number Alterations
    Donaldson, Alana R.
    Shetty, Shashirekha
    Rivera, Christine
    Portier, Bryce P.
    Cook, James R.
    Budd, G. T.
    Downs-Kelly, Erinn
    Klein, Roger D.
    Lanigan, Christopher P.
    Tubbs, Raymond
    Calhoun, Benjamin C.
    LABORATORY INVESTIGATION, 2016, 96 : 40A - 41A
  • [36] The Clinical Utility of Alternative CEP17 Probes in Cases of Equivocal HER2 FISH Results
    Sanders, Mary Ann
    Martin, Alvin
    LABORATORY INVESTIGATION, 2015, 95 : 64A - 64A
  • [37] The Clinical Utility of Alternative CEP17 Probes in Cases of Equivocal HER2 FISH Results
    Sanders, Mary Ann
    Martin, Alvin
    MODERN PATHOLOGY, 2015, 28 : 64A - 64A
  • [38] Impact of Chromosome 17 and HER2 Copy Number Variability on HER2 FISH in Breast Cancer Cases with CEP17 Copy Number Alterations
    Donaldson, Alana R.
    Shetty, Shashirekha
    Rivera, Christine
    Portier, Boyce P.
    Cook, James R.
    Budd, G. T.
    Downs-Kelly, Erinn
    Klein, Roger D.
    Lanigan, Christopher P.
    Tubbs, Raymond
    Calhoun, Benjamin C.
    MODERN PATHOLOGY, 2016, 29 : 40A - 41A
  • [39] Breast Carcinomas with Equivocal HER2/Neu Amplication: Morphologic Features, CEP17 Polysomy and HER2 Genetic Heterogeneity
    Astvatsaturyan, K.
    Bose, S.
    MODERN PATHOLOGY, 2012, 25 : 24A - 25A
  • [40] Breast Carcinomas with Equivocal HER2/Neu Amplification: Morphologic Features, CEP17 Polysomy and HER2 Genetic Heterogeneity
    Astvatsaturyan, K.
    Bose, S.
    LABORATORY INVESTIGATION, 2012, 92 : 24A - 25A
12345